abstract |
The present invention relates to prodrug derivatives of dabigatrans, their use for the treatment and / or prophylaxis of diseases, in particular thrombotic disorders, stroke, myocardial infarction and / or atrial fibrillation and arrhythmias, as well as oncological diseases of any pathogenesis. |